These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 11465075)
41. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048 [TBL] [Abstract][Full Text] [Related]
42. [Molecular mechanize and clinical feature of azole-resistant Candida albicans strains and new strategy of treatment]. Maesaki S Jpn J Antibiot; 2001 Mar; 54(3):126-32. PubMed ID: 11392683 [No Abstract] [Full Text] [Related]
43. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750 [TBL] [Abstract][Full Text] [Related]
44. Transport across Membranes: Techniques for Measuring Efflux in Fungal Cells. Esquivel BD; White TC Methods Mol Biol; 2023; 2658():201-213. PubMed ID: 37024704 [TBL] [Abstract][Full Text] [Related]
45. Multidrug resistance in yeast Candida. Prasad R; Kapoor K Int Rev Cytol; 2005; 242():215-48. PubMed ID: 15598470 [TBL] [Abstract][Full Text] [Related]
46. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system. Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504 [TBL] [Abstract][Full Text] [Related]
47. Molecular bases of antifungal resistance in filamentous fungi. Sharma C; Chowdhary A Int J Antimicrob Agents; 2017 Nov; 50(5):607-616. PubMed ID: 28705674 [TBL] [Abstract][Full Text] [Related]
48. Molecular Detection of Resistance to Azole Components. Posteraro B; Vella A; De Carolis E; Sanguinetti M Methods Mol Biol; 2017; 1508():423-435. PubMed ID: 27837519 [TBL] [Abstract][Full Text] [Related]
49. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762 [TBL] [Abstract][Full Text] [Related]
50. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs. Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389 [TBL] [Abstract][Full Text] [Related]
51. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis. Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412 [TBL] [Abstract][Full Text] [Related]
53. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies. Du W; Gao Y; Liu L; Sai S; Ding C Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576268 [TBL] [Abstract][Full Text] [Related]
54. Candida albicans Clinical Isolates from a Southwest Brazilian Tertiary Hospital Exhibit MFS-mediated Azole Resistance Profile. Pinto ACC; Rocha DAS; Moraes DC; Junqueira ML; Ferreira-Pereira A An Acad Bras Cienc; 2019 Jul; 91(3):e20180654. PubMed ID: 31365653 [TBL] [Abstract][Full Text] [Related]
55. [Advances in the study of Candida albicans gene mutation on azole drug resistance]. Zhu CX; Gao PH; Jiang YY Yao Xue Xue Bao; 2010 Jul; 45(7):821-6. PubMed ID: 20931777 [TBL] [Abstract][Full Text] [Related]